Clinical Trials Logo

Stress Disorder clinical trials

View clinical trials related to Stress Disorder.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT05260541 Terminated - Clinical trials for Post Traumatic Stress Disorder

A Clinical Trial of PRAX-114 in Participants With Post-Traumatic Stress Disorder

Start date: January 25, 2022
Phase: Phase 2
Study type: Interventional

This trial is comprised of a 4-week randomized, double-blind, placebo-controlled treatment period followed by an optional 8-week open-label extension (OLE) period. This trial will evaluate the efficacy and safety of oral PRAX-114 flexibly dosed at 40 to 60 mg for 4 weeks compared to placebo in adults with PTSD. The OLE period consisting of treatment with 40 mg PRAX-114 for 8 weeks will provide additional efficacy and safety data.

NCT ID: NCT04491071 Terminated - Stress Disorder Clinical Trials

Stress Induced by the COVID-19 Pandemic and Nonconfinement: Study of Anxiety Factors and Potential Effects on Immunity.

SCEI
Start date: October 22, 2020
Phase:
Study type: Observational

The aim of this project is to evaluate the impact of pandemic and nonconfinement related to anxiety and eventual immune diseases with several standardized questionnaires : Implant Stability Quotient (ISQ) , Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire -9 (PHQ-9), Post Traumatic Stress Disorder-8 (PTSD-8), and Experiences in Close Relationship Scale (ECRS).